Abstract
The article analyzes the mechanisms of the effect of low-frequency electrostatic field (LESF) and transcranial magnetic stimulation (TMS), as well as their combined use, on various functional systems in patients with metabolic syndrome under placebo control. It was found that LESF activates the microcirculatory-tissue system, while TMS optimizes the hormonal regulation of carbohydrate and lipid metabolism, with both physical factors having approximately equal antithrombolytic and hypotensive effects. When used together, the biological potential of these factors is summed up. The revealed patterns were confirmed in patients with post-COVID syndrome. In addition, they showed a decrease in the activity of inflammatory processes, an improvement in blood oxygen saturation and a decrease in the severity of depression. It is concluded that it is advisable to use these technologies to correct metabolic disorders and increase the effectiveness of the treatment of post-COVID syndrome.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
